SCHEMBL18190481

SCHEMBL18190481

Cc1c(I)cccc1C(=O)Nc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.72
KMT2A Q03164 5/20 0.72
TDP1 Q9NUW8 2/20 0.72
HPGD P15428 4/20 0.62
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
HTT P42858 1/20 0.54
HSD17B10 Q99714 1/20 0.54
METAP2 P50579 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
ALOX12 P18054 1/20 0.51
CHRNB2 P17787 1/20 0.51
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51
CHRNA4 P43681 1/20 0.51
BCAT2 O15382 1/20 0.51
KCNK3 O14649 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benodanil SCHEMBL29402073 0.84 MEN1 (1.00) MEN1KMT2ATDP1HPGDALDH1A1
Benodanil SCHEMBL18736 0.84 MEN1 (1.00) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL27493749 0.83 MEN1 (0.77) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL4138863 0.83 HPGD (0.77) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL28994974 0.81 HPGD (0.74) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL1113047 0.80 MEN1 (0.72) MEN1KMT2ATDP1HPGDALDH1A1
Benodanil SCHEMBL9722166 0.79 MEN1 (0.89) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL28244196 0.79 HPGD (0.60) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL30030085 0.78 KMT2A (0.74) MEN1KMT2ATDP1HPGDALDH1A1
SCHEMBL11590379 0.78 KMT2A (0.74) MEN1KMT2ATDP1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107635970-B Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators 詹森药业有限公司 2021-03-12 CN disclosed
EP-3288936-B1 BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-05-06 EP disclosed
US-10611730-B2 Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2020-04-07 US disclosed
US-20190092735-A1 BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-03-28 US disclosed
EP-3288936-A1 BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2018-03-07 EP disclosed
WO-2016176449-A1 BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10611730-B2 Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators GRIN1, GABRE, GRIN3A MEN1 3374/4885KMT2A 2314/4885TDP1 3001/4885
US-20190092735-A1 BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS GRIN1, GABRE, GRIN3A MEN1 3374/4885KMT2A 2314/4885TDP1 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.